Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 2.80 is in line with its 5-year average of 2.67, near the high end of its 5-year range (0.81–3.20).
As of the fiscal period ended Tuesday, June 30, 2026. 8.14% above its 12-month average of 2.59.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 2.80.
CURRENT RATIO
2.80
CURRENT RATIO AVG TTM
2.59
CURRENT RATIO AVG 3Y
2.68
CURRENT RATIO AVG 5Y
2.67
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+8.14%
CURRENT VS 3Y AVG
+4.18%
CURRENT VS 5Y AVG
+4.88%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.76
median of 873 covered companies
CURRENT VS SECTOR MEDIAN
-25.65%
vs the sector median at left
Market Cap
$5.21B
Current Ratio
4.05
TTM Avg
2.41
3Y Avg
2.93
5Y Avg
3.47
Market Cap
$5.21B
Current Ratio
17.85
TTM Avg
17.70
3Y Avg
17.06
5Y Avg
17.77
Market Cap
$5.19B
Current Ratio
13.57
TTM Avg
9.78
3Y Avg
9.13
5Y Avg
11.38
Market Cap
$5.09B
Current Ratio
7.02
TTM Avg
8.28
3Y Avg
8.59
5Y Avg
7.77
Market Cap
$5.07B
Current Ratio
4.20
TTM Avg
4.30
3Y Avg
4.12
5Y Avg
3.47
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Sotera Health Company (SHC) | $5.20B | 2.80 | 2.59 | 2.68 | 2.67 |
| Travere Therapeutics, Inc. (TVTX)vs › | $5.21B | 4.05 | 2.41 | 2.93 | 3.47 |
| CRISPR Therapeutics AG (CRSP)vs › | $5.21B | 17.85 | 17.70 | 17.06 | 17.77 |
| Doximity, Inc. (DOCS)vs › | $5.20B | 6.08 | 6.53 | 6.56 | 6.07 |
| Cogent Biosciences, Inc. (COGT)vs › | $5.19B | 13.57 | 9.78 | 9.13 | 11.38 |
| PTC Therapeutics, Inc. (PTCT)vs › | $5.32B | 3.39 | 2.35 | 2.11 | 2.46 |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.09B | 7.02 | 8.28 | 8.59 | 7.77 |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.07B | 4.20 | 4.30 | 4.12 | 3.47 |
| Waystar Holding Corp. (WAY)vs › | $5.06B | 1.85 | 1.98 | 1.97 | 1.88 |
| Erasca, Inc. (ERAS)vs › | $4.96B | 8.29 | 9.94 | 10.32 | 11.01 |
Current Ratio
2.80
Quick Ratio
2.53
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 2.80 |
| 2026-03-31 | 2.82 |
| 2025-12-31 | 2.46 |
| 2025-09-30 | 2.38 |
| 2025-06-30 | 2.47 |
| 2025-03-31 | 2.46 |
| 2024-12-31 | 2.75 |
| 2024-09-30 | 2.88 |
| 2024-06-30 | 2.93 |
| 2024-03-31 | 3.20 |
| 2023-12-31 | 2.42 |
| 2023-09-30 | 2.59 |
| 2023-06-30 | 2.73 |
| 2023-03-31 | 1.54 |
| 2022-12-31 | 0.81 |
| 2022-09-30 | 3.00 |
| 2022-06-30 | 2.81 |
| 2022-03-31 | 2.58 |
| 2021-12-31 | 2.15 |
| 2021-09-30 | 2.52 |
| 2021-06-30 | 2.70 |
| 2021-03-31 | 2.38 |
| 2020-12-31 | 2.24 |
| 2020-09-30 | 2.13 |
| 2020-06-30 | 2.09 |
| 2020-03-31 | 0.00 |
| 2019-12-31 | 2.04 |
| 2019-09-30 | 0.00 |
| 2019-06-30 | 0.00 |
| 2019-03-31 | 0.00 |
